KATIE BARRICK-JONES: Open Payments
NPI 1932415627 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 21 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $61 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $177 |
| Lundbeck LLC | 7 | $130 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
| Vertical Pharmaceuticals, LLC | 1 | $24 |
Products named: CAPLYTA, REXULTI, SPRAVATO, Relexxii.
Industry payments across MD — which companies pay providers there.
